Technical Core A is the infrastructural support that provides the following critical services to the projects: 1. Specimen Acquisition, Processing, Storage and Accession A major activity of Core A will be specimen acquisition, processing, storage and accession. The tissue acquisition aspect involves surgical and rapid autopsy programs and is directed by Larry True, our GU pathologist. From these tissues we also prepare and store RNA and cDNA in a standardized, quality controlled fashion from tissues, cell lines and xenografts. Another aspect of specimen acquisition involves maintenance of the serum bank by which the Core provides well- documented clinical specimens for study. 2. RT-PCR, Immunohistochemistry and In situ Hybridization Services The Core will provide RET-PCR, immunohistochemistry and in situ hybridization technical support ranging from simple supply of cut tissue sections to the full execution of the study. 3. PSA and Other Immunoassay Services Core A will provide PSA determinations on serum (human and from mice bearing CaP xenografts) and tissue culture fluids. It will help develop new, research immunoassays (e.g. prostase, TMPRS22; see Project III). 4. Tissue Culture Services Core A will also provide full tissue culture service. This will range from simply preparing a batch of cells (e.g. osteoblast cells for Project II) to determining serine protease levels in supernatant fluids of LNCaP before and after androgen stimulation (e.g. prostase, Project III). 5. CaP and Control Xenograft Maintenance plus Perform All Xenograft Studies The most extensive service provided by Core A involves maintenance of the xenograft facility and performance of all xenograft studies within the Program. We are uniquely well positioned to conduct these complex animal model studies because of our extensive experience in developing and characterizing the LNCaP series of xenografts. Core A will also develop new lines, primarily utilizing the rapid autopsy approach with a new emphasis on establishing xenografts from bone metastases.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA085859-01A2
Application #
6594331
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-05-01
Project End
2007-04-30
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Montgomery, Bruce; Tretiakova, Maria S; Joshua, Anthony M et al. (2017) Neoadjuvant Enzalutamide Prior to Prostatectomy. Clin Cancer Res 23:2169-2176
Martin, P L; Yin, J-J; Seng, V et al. (2017) Androgen deprivation leads to increased carbohydrate metabolism and hexokinase 2-mediated survival in Pten/Tp53-deficient prostate cancer. Oncogene 36:525-533
Suominen, Mari I; Fagerlund, Katja M; Rissanen, Jukka P et al. (2017) Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models. Clin Cancer Res 23:4335-4346
Don-Doncow, Nicholas; Marginean, Felicia; Coleman, Ilsa et al. (2017) Expression of STAT3 in Prostate Cancer Metastases. Eur Urol 71:313-316
Haider, Maahum; Zhang, Xiaotun; Coleman, Ilsa et al. (2016) Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases. Clin Exp Metastasis 33:239-48
Wu, Yu; Davison, Jerry; Qu, Xiaoyu et al. (2016) Methylation profiling identified novel differentially methylated markers including OPCML and FLRT2 in prostate cancer. Epigenetics 11:247-58
Van Allen, Eliezer M; Robinson, Dan; Morrissey, Colm et al. (2016) A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine. Oncotarget 7:52888-52899
Brocqueville, Guillaume; Chmelar, Renee S; Bauderlique-Le Roy, Hélène et al. (2016) s-SHIP expression identifies a subset of murine basal prostate cells as neonatal stem cells. Oncotarget 7:29228-44
Qu, Xiaoyu; Jeldres, Claudio; Glaskova, Lena et al. (2016) Identification of Combinatorial Genomic Abnormalities Associated with Prostate Cancer Early Recurrence. J Mol Diagn 18:215-24
Wu, Yu; Schoenborn, Jamie R; Morrissey, Colm et al. (2016) High-Resolution Genomic Profiling of Disseminated Tumor Cells in Prostate Cancer. J Mol Diagn 18:131-43

Showing the most recent 10 out of 157 publications